Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B [Phase 3]

View source ↗

Summary

A Phase 3 study comparing the pharmacokinetics and safety of Replenine®-VF, Replenine®, and other Factor IX products in Hemophilia B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Other Factor IX products (Factor IX concentrate)
• Replenine® (Factor IX concentrate)
• Replenine®-VF (Factor IX concentrate)

Snippet

Sponsor: Bio Products Laboratory | Conditions: Haemophilia B | Phase 3 | Status: COMPLETED